|
1
|
Juliusson G and Hough R: Leukemia. Prog
Tumor Res. 43:87–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamashita Y, Yuan J, Suetake I, Suzuki H,
Ishikawa Y, Choi YL, Ueno T, Soda M, Hamada T, Haruta H, et al:
Array-based genomic resequencing of human leukemia. Oncogene.
29:3723–3731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steinmaus C and Smith MT: Steinmaus and
Smith respond to 'proximity to gasoline stations and childhood
leukemia'. Am J Epidemiol. 185:5–7. 2017. View Article : Google Scholar
|
|
4
|
Kabat GC, Wu JW, Moore SC, Morton LM, Park
Y, Hollenbeck AR and Rohan TE: Lifestyle and dietary factors in
relation to risk of chronic myeloid leukemia in the NIH-AARP Diet
and Health Study. Cancer Epidemiol Biomarkers Prev. 22:848–854.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kosmider O, Gelsi-Boyer V, Slama L,
Dreyfus F, Beyne-Rauzy O, Quesnel B, Hunault-Berger M, Slama B, Vey
N, Lacombe C, et al: Mutations of IDH1 and IDH2 genes in early and
accelerated phases of myelodysplastic syndromes and
MDS/myeloproliferative neoplasms. Leukemia. 24:1094–1096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Papeta N, Zheng Z, Schon EA, Brosel S,
Altintas MM, Nasr SH, Reiser J, D'Agati VD and Gharavi AG: Prkdc
participates in mitochondrial genome maintenance and prevents
adriamycin-induced nephropathy in mice. J Clin Invest.
120:4055–4064. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Escherich G, Zimmermann M and Janka-Schaub
G; CoALL study group: Doxorubicin or daunorubicin given upfront in
a therapeutic window are equally effective in children with newly
diagnosed acute lymphoblastic leukemia. A randomized comparison in
trial CoALL 07-03. Pediatr Blood Cancer. 60:254–257. 2013.
View Article : Google Scholar
|
|
8
|
Wang Y, Krivtsov AV, Sinha AU, North TE,
Goessling W, Feng Z, Zon LI and Armstrong SA: The Wnt/beta-catenin
pathway is required for the development of leukemia stem cells in
AML. Science. 327:1650–1653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomes BC, Rueff J and Rodrigues AS:
MicroRNAs and cancer drug resistance. Methods Mol Biol.
1395:137–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bousquet M, Harris MH, Zhou B and Lodish
HF: MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA.
107:21558–21563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lindsley RC and Ebert BL: Molecular
pathophysiology of myelodysplastic syndromes. Annu Rev Pathol.
8:21–47. 2013. View Article : Google Scholar
|
|
13
|
Xia H, Yamada S, Aoyama M, Sato F, Masaki
A, Ge Y, Ri M, Ishida T, Ueda R, Utsunomiya A, et al: Prognostic
impact of microRNA-145 down-regulation in adult T-cell
leukemia/lymphoma. Hum Pathol. 45:1192–1198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian Y, Tian X, Han X, Chen Y, Song CY,
Jiang WJ and Tian DL: ABCE1 plays an essential role in lung cancer
progression and metastasis. Tumour Biol. 37:8375–8382. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Jonge-Peeters SD, Kuipers F, de Vries
EG and Vellenga E: ABC transporter expression in hematopoietic stem
cells and the role in AML drug resistance. Crit Rev Oncol Hematol.
62:214–226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Li W, Jiang Y, Wang Y, Yang S, Bi X, Pan
X, Ma A and Li W: MiR-181b regulates autophagy in a model of
Parkinson's disease by targeting the PTEN/Akt/mTOR signaling
pathway. Neurosci Lett. 675:83–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu W, He J, Yang Y, Guo Q and Gao F:
Upregulating miR-146a by physcion reverses multidrug resistance in
human chronic myelogenous leukemia K562/ADM cells. Am J Cancer Res.
6:2547–2560. 2016.PubMed/NCBI
|
|
19
|
Bose P, Vachhani P and Cortes JE:
Treatment of relapsed/refractory acute myeloid leukemia. Curr Treat
Options Oncol. 18:172017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Ai Z, Chen J, Yi J, Liu Z, Zhao H
and Wei H: Glycometabolic adaptation mediates the insensitivity of
drug-resistant K562/ADM leukaemia cells to adriamycin via the
AKT-mTOR/c-Myc signalling pathway. Mol Med Rep. 15:1869–1876. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang
H, Hong M, Jiang T, Jiang Q, Lu J, et al: An oncogenic role of
miR-142-3p-in human T-cell acute lymphoblastic leukemia (T-ALL) by
targeting gluco-corticoid receptor-α and cAMP/PKA pathways.
Leukemia. 26:769–777. 2012. View Article : Google Scholar
|
|
22
|
Wang F, Chen J, Zhang Z, Yi J, Yuan M,
Wang M, Zhang N, Qiu X, Wei H and Wang L: Differences of basic and
induced autophagic activity between K562 and K562/ADM cells.
Intractable Rare Dis Res. 6:281–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang MY, Lin PM, Liu YC, Hsiao HH, Yang
WC, Hsu JF, Hsu CM and Lin SF: Induction of cellular senescence by
doxorubicin is associated with upregulated miR-375 and induction of
autophagy in K562 cells. PLoS One. 7:e372052012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stefan K, Schmitt SM and Wiese M:
9-Deazapurines as broad-spectrum inhibitors of the ABC transport
proteins P-glycoprotein, multidrug resistance-associated protein 1,
and breast cancer resistance protein. J Med Chem. 60:8758–8780.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao L, Haque A, Jackson K, Hazari S, Moroz
K, Jetly R and Dash S: Increased expression of P-glycoprotein is
associated with doxorubicin chemoresistance in the metastatic 4T1
breast cancer model. Am J Pathol. 178:838–852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge C, Cao B, Feng D, Zhou F, Zhang J, Yang
N, Feng S, Wang G and Aa J: The down-regulation of SLC7A11 enhances
ROS induced P-gp over-expression and drug resistance in MCF-7
breast cancer cells. Sci Rep. 7:37912017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang M, Lin L, Cai H, Tang J and Zhou Z:
MicroRNA-145 downregulation associates with advanced tumor
progression and poor prognosis in patients suffering osteosarcoma.
Onco Targets Ther. 6:833–838. 2013.PubMed/NCBI
|
|
28
|
Zhang H, Luo Y, Xu W, Li K and Liao C:
Silencing long inter-genic non-coding RNA 00707 enhances cisplatin
sensitivity in cisplatin-resistant non-small-cell lung cancer cells
by sponging miR-145. Oncol Lett. 18:6261–6268. 2019.PubMed/NCBI
|
|
29
|
Zhang JH, Du AL, Wang L, Wang XY, Gao JH
and Wang TY: Episomal lentiviral vector-mediated miR-145
overexpression inhibits proliferation and induces apoptosis of
human esopha-geal carcinomas cells. Recent Pat Anticancer Drug
Discov. 11:453–460. 2016. View Article : Google Scholar
|
|
30
|
Gao M, Miao L, Liu M, Li C, Yu C, Yan H,
Yin Y, Wang Y, Qi X and Ren J: miR-145 sensitizes breast cancer to
doxorubicin by targeting multidrug resistance-associated protein-1.
Oncotarget. 7:59714–59726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantei K and Wood BL: Flow cytometric
evaluation of CD38 expression assists in distinguishing follicular
hyperplasia from follicular lymphoma. Cytometry B Clin Cytom.
76:315–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang F, Wang XK, Shi CJ, Zhang H, Hu YP,
Chen YF and Fu LW: Nilotinib enhances the efficacy of conventional
chemo-therapeutic drugs in CD34+CD38− stem
cells and ABC transporter overexpressing leukemia cells. Molecules.
19:3356–3375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yalçintepe L, Halis E and Ulku S: Effect
of CD38 on the multi-drug resistance of human chronic myelogenous
leukemia K562 cells to doxorubicin. Oncol Lett. 11:2290–2296. 2016.
View Article : Google Scholar
|
|
34
|
Ikemura K, Yamamoto M, Miyazaki S,
Mizutani H, Iwamoto T and Okuda M: MicroRNA-145
post-transcriptionally regulates the expression and function of
P-glycoprotein in intestinal epithelial cells. Mol Pharmacol.
83:399–405. 2013. View Article : Google Scholar
|
|
35
|
Zheng TL, Li DP, He ZF and Zhao S: miR-145
sensitizes esophageal squamous cell carcinoma to cisplatin through
directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int.
19:2502019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paprocka M, Bielawska-Pohl A, Rossowska J,
Krawczenko A, Duś D, Kiełbiński M, Haus O, Podolak-Dawidziak M and
Kuliczkowski K: MRP1 protein expression in leukemic stem cells as a
negative prognostic marker in acute myeloid leukemia patients. Eur
J Haematol. 99:415–422. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raaijmakers MH: ATP-binding-cassette
transporters in hematopoietic stem cells and their utility as
therapeutical targets in acute and chronic myeloid leukemia.
Leukemia. 21:2094–2102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kara G, Tuncer S, Türk M and Denkbas EB:
Downregulation of ABCE1 via siRNA affects the sensitivity of A549
cells against chemotherapeutic agents. Med Oncol. 32:1032015.
View Article : Google Scholar : PubMed/NCBI
|
